1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Joseph Paul Eder: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OLAParib COmbinations AZD2281, AZD5363, AZD1775 - Cancer | Phase 2 | Terminated | Joseph Paul Eder | 67 | 2015-11-01 | 2022-12-28 |
Neoplasms (1)
adavosertib (1) · capivasertib (1) · ceralasertib (1) · olaparib (1)
United States (1)